These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37510647)

  • 21. Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.
    Velavan TP; Kuk S; Linh LTK; Lamsfus Calle C; Lalremruata A; Pallerla SR; Kreidenweiss A; Held J; Esen M; Gabor J; Neurohr EM; Shamsrizi P; Fathi A; Biecker E; Berg CP; Ramharter M; Addo MM; Kreuels B; Kremsner PG
    Sci Rep; 2021 Jul; 11(1):14471. PubMed ID: 34262116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection.
    WAPM (World Association of Perinatal Medicine) Working Group on COVID-19
    Ultrasound Obstet Gynecol; 2021 Feb; 57(2):232-241. PubMed ID: 32926494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do Laboratory Biomarkers Predict Survival In Severe Covid-19? A Cross-Sectional Study.
    Bahadur S; Rahim F; Amin S; Noor M; Gul H; Mahmood A; Usman M; Ullah R; Khan MA; Shahab K
    J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(4):S919-S922. PubMed ID: 36550644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic.
    Balachandren N; Davies MC; Hall JA; Stephenson JM; David AL; Barrett G; O'Neill HC; Ploubidis GB; Yasmin E; Mavrelos D
    Hum Reprod; 2022 May; 37(6):1126-1133. PubMed ID: 35389480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 in solid organ transplant recipients: Dynamics of disease progression and inflammatory markers in ICU and non-ICU admitted patients.
    Roberts MB; Izzy S; Tahir Z; Al Jarrah A; Fishman JA; El Khoury J
    Transpl Infect Dis; 2020 Oct; 22(5):e13407. PubMed ID: 32654303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The study of serum hsCRP, ferritin, IL-6 and plasma D-dimer in COVID-19: a retrospective study.
    Ahirwar AK; Takhelmayum R; Sakarde A; Rathod BD; Jha PK; Kumawat R; Gopal N
    Horm Mol Biol Clin Investig; 2022 Sep; 43(3):337-344. PubMed ID: 35357792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The rate of SARS-CoV-2 positivity in asymptomatic pregnant women admitted to hospital for delivery: Experience of a pandemic center in Turkey.
    Tanacan A; Erol SA; Turgay B; Anuk AT; Secen EI; Yegin GF; Ozyer S; Kirca F; Dinc B; Unlu S; Yapar Eyi EG; Keskin HL; Sahin D; Surel AA; Tekin OM
    Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():31-34. PubMed ID: 32763728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.
    Hachim IY; Hachim MY; Hannawi H; Naeem KB; Salah A; Hannawi S
    PLoS One; 2021; 16(12):e0260537. PubMed ID: 34855832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of nutritional status on clinical outcomes among hospitalized patients with COVID-19.
    Nicolau J; Ayala L; Sanchís P; Olivares J; Dotres K; Soler AG; Rodríguez I; Gómez LA; Masmiquel L
    Clin Nutr ESPEN; 2021 Jun; 43():223-229. PubMed ID: 34024518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics and laboratory results of pregnant women with COVID-19 in Wuhan, China.
    Wang Z; Wang Z; Xiong G
    Int J Gynaecol Obstet; 2020 Sep; 150(3):312-317. PubMed ID: 32510581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Routine screening for SARS CoV-2 in unselected pregnant women at delivery.
    Díaz-Corvillón P; Mönckeberg M; Barros A; Illanes SE; Soldati A; Nien JK; Schepeler M; Caradeux J
    PLoS One; 2020; 15(9):e0239887. PubMed ID: 32991621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood biochemical parameters for assessment of COVID-19 in diabetic and non-diabetic subjects: a cross-sectional study.
    Malik SUF; Chowdhury PA; Hakim A; Islam MS; Alam MJ; Azad AK
    Int J Environ Health Res; 2022 Jun; 32(6):1344-1358. PubMed ID: 33504213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 infection in pregnant women and newborns in two maternity hospitals in Salvador-Bahia, Brazil.
    Moreira LMO; Patiño J; Oliveira PR; Costa MHM; Santiago AC; Campos GS; Sardi SI; Menezes C; Lyra PPR; Netto EM
    Braz J Infect Dis; 2021; 25(3):101591. PubMed ID: 34133953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of systemic inflammation biomarkers and disease severity in pregnant women with COVID-19.
    Gündüz Ö; Seven B; Ozgu-Erdınc AS; Ayhan SG; Sahin D; Tekin OM; Keskin HL
    Rev Assoc Med Bras (1992); 2023; 69(6):e20221614. PubMed ID: 37377284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An internally validated prediction model for critical COVID-19 infection and intensive care unit admission in symptomatic pregnant women.
    Kalafat E; Prasad S; Birol P; Tekin AB; Kunt A; Di Fabrizio C; Alatas C; Celik E; Bagci H; Binder J; Le Doare K; Magee LA; Mutlu MA; Yassa M; Tug N; Sahin O; Krokos P; O'brien P; von Dadelszen P; Palmrich P; Papaioannou G; Ayaz R; Ladhani SN; Kalantaridou S; Mihmanli V; Khalil A
    Am J Obstet Gynecol; 2022 Mar; 226(3):403.e1-403.e13. PubMed ID: 34582796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laboratory analysis of symptomatic and asymptomatic pregnant patients with SARS-CoV-2 infection.
    Fisher SA; Goldstein JA; Mithal LB; Isaia AL; Shanes ED; Otero S; Miller ES
    Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100458. PubMed ID: 34403821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 infection in pregnancy during the first wave of COVID-19 in the Netherlands: a prospective nationwide population-based cohort study (NethOSS).
    Overtoom EM; Rosman AN; Zwart JJ; Vogelvang TE; Schaap TP; van den Akker T; Bloemenkamp K
    BJOG; 2022 Jan; 129(1):91-100. PubMed ID: 34494694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 in pregnant women: An evaluation of clinical symptoms and laboratory parameters based on the 3 trimesters.
    Tunç Ş; Göklü MR; Oğlak SC
    Saudi Med J; 2022 Apr; 43(4):378-385. PubMed ID: 35414616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.